Pfizer’s MenB vaccine (Trumenba) sales rise 20% by Q3 2027 amid outbreak

The confirmed Meningitis B case and public health response will drive increased demand for MenB vaccines. Pfizer’s Trumenba, a leading MenB vaccine, is expected to see a significant sales boost as schools and parents prioritize vaccination.

Implied probability (Yes)

70%

Closes

2027-12-31